NCT06152809 2026-03-18
CIML NK Cells With Venetoclax for AML
Dana-Farber Cancer Institute
Phase 1 Recruiting
Dana-Farber Cancer Institute
Radboud University Medical Center
Essen Biotech
Washington University School of Medicine
Dana-Farber Cancer Institute